Showing results (471-480 of 491) with videos related to

Sort By:
Pageof 50
Kidney International|March 10, 2022
High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with kidney impairmentPeter J Gallacher, Eve Miller-Hodges, Anoop S V Shah, et al.
The New England Journal of Medicine|March 15, 2006
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsDeepak L Bhatt, Keith A A Fox, Werner Hacke, et al.
European Heart Journal|August 29, 2025
Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imagingTina Stegmann, Raed A Joundi, Abhilekh Srivastava, et al.
The New England Journal of Medicine|May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular DiseaseA Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Lancet (London, England)|November 15, 2017
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trialStuart J Connolly, John W Eikelboom, Jackie Bosch, et al.
JAMA|April 5, 2016
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical TrialMichelle L O'Donoghue, Ruchira Glaser, Matthew A Cavender, et al.
Lancet (London, England)|November 15, 2017
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trialSonia S Anand, Jackie Bosch, John W Eikelboom, et al.
The New England Journal of Medicine|September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial InfarctionVijay Kunadian, Helen Mossop, Carol Shields, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
Lancet (London, England)|September 2, 2018
High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trialAnoop S V Shah, Atul Anand, Fiona E Strachan, et al.
Pageof 50